A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections.
Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N.
Epidemiol Infect. 2009 Mar 19:1-9. [Epub ahead of print]
PMID: 19296870
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.
Ginde AA, Mansbach JM, Camargo CA Jr.
Arch Intern Med. 2009 Feb 23;169(4):384-90.
PMID: 19237723
Conclusions Serum 25(OH)D levels are inversely associated with recent URTI. This association may be stronger in those with respiratory tract diseases. Randomized controlled trials are warranted to explore the effects of vitamin D supplementation on RTI.
Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection. \nAdit A. Ginde, MD, MPH; Jonathan M. Mansbach, MD; Carlos A. Camargo Jr, MD, DrPH . \nArch Intern Med. 2009;169(4):384-390\n